qsif SIF · SIF · SIF-117
qsif Sector Rotation Long-Short Fund - Growth Option - RegularPlan
Equity Oriented · Sector Rotation Long-Short Fund · Open Ended Scheme · Regular Growth
ISIN (Payout): INF966L30308
Strategy facts
- Declared benchmark
- NIFTY 500 Total Return Index (TRI)
- Fund managers
- Sandeep Tandon (since May 2026), Jignesh Shah (since May 2026), Ankit Pande (since May 2026), Sameer Kate (since May 2026), Sanjeev Sharma (since May 2026)
- Launched
- 27 Apr 2026
- Minimum investment
- ₹10 lakh
- Risk level (1 low, 5 high)
- Level 3 (was Level 5 at launch)
- Expense ratio, as filed with AMFI
- Regular: 4.36% Direct: 2.81%
Houses fill this field differently. It may be the base expense ratio only, before GST, brokerage and transaction costs.
- Custodian
- HDFC Bank Limited
- SEBI code
- QSIF/O/E/SRLS/25/10/0005/QNTM
- Exit load
- Exit Load: 3% if redeemed/switched out on or before completion of 30 days from the date of allotment of units No Exit Load is payable if Units are redeemed / switched-out after 30 days from the date of allotment
Investment objective
To achieve long-term capital appreciation by concentrating investments in equity and equity-related instruments of up to four high-potential sectors, while employing limited short exposure through derivatives to capitalize on sector-specific downturns and enhance risk-adjusted returns.
From AMFI's strategy details and the house's Scheme Summary Document, checked 16 Oct 2026. Strategy document (PDF) Summary document (PDF)
Returns (as of 2026-10-21)
1 Month
-2.97%
3 Months
-1.80%
6 Months
—
Since Inception
+0.47%
from 2026-05-18
CAGR (Inception)
—
< 1 yr history
Risk Indicators
Max Drawdown
-3.68%
Worst peak‑to‑trough fall since inception
Annualised Volatility
7.80%
How bumpy the daily NAV journey is
Based on 156 days of NAV history. Green < 5% MDD / < 12% vol · Amber 5-10% / 12-20% · Red > 10% / > 20%
Risk-adjusted ratios
Since inception, from 107 daily returns. Short histories make these noisy, so treat them as provisional.
Sharpe ratio
-0.59
Return per unit of total risk, above a 6% risk-free rate
Sortino ratio
-0.81
Same, but counting only the falls
Beta vs Nifty 500
0.36
1.0 moves with the index; lower means more hedged
Down capture
27%
Share of the index's falls it took on down days (lower is better)
Up capture
32%
Share of the index's gains it kept on up days
Worst month
-1.01%
Jul 2026
Best month
1.60%
Aug 2026
Positive months
3 of 5
Completed calendar months that gained
Drawdown recovery
Not yet
0 days since the worst low
Below its high
-3.68%
How far today's NAV is under the highest NAV so far
Beta and capture use the Nifty 500 price index, matched on 107 common trading days.
Portfolio · as on 30 Sep 2026
House's portfolio fileStrategy assets
₹62 cr
Net assets in the portfolio file
Equity held
70.3%
14 stocks, top 10 = 62.5%
Futures, net
-12.5%
Short -22.4% · long +10.0%
Net equity exposure
57.8%
Equity held plus futures
How the book is built
Arbitrage: 22% of NAV is stock held against its own short futures.
Each future and option is matched to the stock it is written on, and coverage is measured by contracts against shares held: the file shows options at their premium, which would make a collar over half the book look like well under 1% of it.
Asset mix, % of net assets
- Equity held +70.3%
- Cash & TREPS +19.8%
- Futures -12.5%
- Money market +6.4%
- Net receivables +3.6%
Blue bars add to the portfolio, orange bars are short or negative positions.
Top 10 stocks held
| Indus Towers LimitedTelecom - Services | 9.33% |
| Zydus Lifesciences LimitedPharmaceuticals & Biotechnology | 8.77% |
| Divi's Laboratories LimitedPharmaceuticals & Biotechnology | 7.18% |
| Bharti Airtel LimitedTelecom - Services | 6.78% |
| Gujarat Themis Biosyn LtdPharmaceuticals & Biotechnology | 5.81% |
| Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology | 5.68% |
| Glenmark Pharmaceuticals LtdPharmaceuticals & Biotechnology | 5.61% |
| Lupin LimitedPharmaceuticals & Biotechnology | 5.28% |
| Biocon LtdPharmaceuticals & Biotechnology | 4.89% |
| Mphasis LtdIT - Software | 3.12% |
Largest short positions (4 in total)
| Bharti Airtel Ltd.Futures | -6.76% |
| Sun Pharmaceutical Industries Ltd.Futures | -5.68% |
| Lupin Ltd.Futures | -5.18% |
| Biocon Ltd.Futures | -4.82% |
Stocks held, by industry
Net assets by portfolio date: Sep 2026 ₹62 cr · Jul 2026 ₹49 cr
From the house's own portfolio statement; SIFs must publish one at least every alternate month-end. Futures are counted at full contract value, so net equity exposure is equity held plus futures. Options are shown at their premium value, not their market exposure, so they are left out of that figure.
Growth of ₹100 since inception
2026-05-18 → 2026-10-21
| Since inception | Return | Max drawdown |
|---|
All rebased to ₹100 at the SIF's inception. SIFs are long-short (hedged) and aim for a smaller max drawdown rather than out-running a fully-invested fund/index in a rising market, so weigh the drawdown column alongside return.
Fund house's own money in this strategy
| Quarter | Valued on | ₹ crore |
|---|---|---|
| Apr-Jun 2026 | 30 Jun 2026 | 0.01 |
What the fund house itself has invested in this strategy, as filed with AMFI each quarter. This is the house's own stake, not the size of the strategy (AUM). AMFI does not publish AUM for individual SIF strategies.
Monthly returns · since inception (May 2026)
How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | · | · | · | · | +1.3 | -1.0 | +1.6 | -0.1 | -1.8 | · | · | -0.1 |
| Avg | · | · | · | · | · | +1.3 | -1.0 | +1.6 | -0.1 | · | · | · | · |
All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row.
Other plans: qsif SIF · Sector Rotation Long-Short Fund
Minimum investment ₹10 lakh. SIF data from AMFI. Not investment advice. Verify all information with the fund house before investing.